⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2010Molecular TherapyOpen Access

Safer CARS

View Full Paper

Ask AI

Bookmark

Share

Authors

HHHelen E. HeslopUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Helen E. Heslop (2010) studied this question.

synapsesocial.com/papers/6a9422d78e5b8037ce440409 https://doi.org/10.1038/mt.2010.42

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN14122006 · 2,174 citations
2Graft-versus-leukemia effects of transplantation and donor lymphocytes2008 · 584 citations
3Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens2010 · 232 citations
4Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells2008 · 727 citations
5Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell Transplantation2007 · 208 citations